KURA
Kura Oncology
$10.15
−$0.24 (−2.31%)Jul 27, 2026
Key metrics
The numbers that frame KURA today
- Market cap
- $901.06M
- P/E (TTM)
- -3.1
- EV / FCF
- -10.5
- Gross margin
- 99.6%
- EV / Sales
- 12.4
- ROIC
- -58.8%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $5.45
- 52wk High
- $12.49
Growth
Revenue and earnings trend for KURA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about KURA
Is Kura Oncology a good buy?
Hold. Kura Oncology has excellent momentum, but weak quality makes the setup mixed. Growth looks strong, which supports the long-term business case. We think Kura Oncology is selling at a very high price.
What is the market capitalization of KURA?
Kura Oncology's market capitalization is $901.06M.
What is the P/E ratio for KURA stock?
Kura Oncology's current P/E ratio is -3.1.
What is the 52-week high for KURA stock?
The 52-week high for Kura Oncology is $12.49. The current close of $10.15 is 18.7% below that high.
What is the 52-week low for KURA stock?
The 52-week low for Kura Oncology is $5.45. The current close of $10.15 is 86.2% above that low.
Does KURA stock pay dividends?
Kura Oncology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for KURA?
Kura Oncology's Debt / Equity ratio is 0.23.